Skip to main content

Applications of FDG-PET in Central Nervous System Disorders, An Issue of PET Clinics

  • 1st Edition, Volume 21-4 - September 9, 2026
  • Latest edition
  • Editors: Andrew B. Newberg, Eric Guedj, Abass Alavi
  • Language: English

In this issue of PET Clinics, guest editors Drs. Andrew B. Newberg, Eric Guedj, and Abass Alavi bring their considerable expertise to the topic of Applications of FDG-PET in… Read more

Purchase options

Description

In this issue of PET Clinics, guest editors Drs. Andrew B. Newberg, Eric Guedj, and Abass Alavi bring their considerable expertise to the topic of Applications of FDG-PET in Central Nervous System Disorders. This issue is the first of four that describes the revolutionary impact of FDG-PET on the day-to-day practice of medicine during the past five decades. Top experts discuss key topics in the areas of Foundations and Normal Brain; Neurodegenerative and Movement Disorders; Epilepsy, Tumors, Structural Damage, Inflammation, and Infection; Psychiatric, Functional, and Subjective Disorders; and Clinical Impact and Future Directions.

Key features

  • Contains 13 relevant, practice-oriented topics including FDG-PET in cognitive impairment and dementia; FDG-PET in brain tumors; FDG-PET in traumatic brain injury and post-concussive sequelae; FDG-PET in major psychiatric disorders; future directions for FDG-PET in CNS diseases: AI, big data, and network approaches; and more.
  • Provides in-depth clinical reviews on applications of FDG-PET in central nervous system disorders, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Readership

Radiology, nuclear medicine

Table of contents

18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026
Normal Patterns and Variants in PET Brain Imaging from Childhood to Aging
FDG-PET in Cognitive Impairment and Dementia
FDG-PET in Movement Disorders and Parkinsonian Syndromes

2-[ 18 F]fluoro-2-deoxy-D-glucose PET in Brain Tumors
FDG-PET in Traumatic Brain Injury and Postconcussive Sequelae
Brain [18F]FDG-PET in Encephalitis and Postinfectious Neurocognitive Syndromes

18 F-fluorodeoxyglucose PET in Major Psychiatric Disorders
Brain [18F]FDG-PET in Subjective Cognitive Complaints: From Diagnostic Gap to Neurobiological Insight
Fluorodeoxyglucose PET and Consciousness
Fluorodeoxyglucose PET Scans in the Integrative Medicine Setting
How Fluorine-18-labeled Fluorodeoxyglucose PET Changed Clinical Practice in Central Nervous System Disorders
Future Directions for [18F]FDG PET in Central Nervous System Diseases

Product details

  • Edition: 1
  • Latest edition
  • Volume: 21-4
  • Published: September 9, 2026
  • Language: English

About the editors

Andrew B. Newberg

Editor
Affiliations and expertise
Marcus Institute of Integrative Health Thomas Jefferson University, Villanova, PA, USA

Abass Alavi

Editor
Affiliations and expertise
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA